BiMix Plus Injectable Recalled Due to Lack of Sterility Assurance
Axium Healthcare Pharmacy is recalling BiMix Plus Injectable due to lack of sterility assurance and quality control concerns.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance in injectable products, which poses a significant risk of serious injury or death from infection.
Plain-English summary
Axium Healthcare Pharmacy dba Balanced Solutions Compounding is recalling BiMix Plus Injectable Balanced Solutions. The recall involves 6 vials (5 mL and 10 mL each) distributed to Colorado, Georgia, Michigan, and Puerto Rico.
The recall was initiated because of a lack of assurance of sterility for all sterile products compounded, repackaged, and distributed by the pharmacy. The agency cited concerns associated with the quality control processes.
Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for instructions on disposal or replacement.
The recalled product
- Product
- BiMix Plus Injectable Balanced Solutions, Compounding Pharmacy a division of Axium Healthcare Pharmacy, Inc., Lake Mary, FL 32746
- Category
- Drug — Compounded Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- ALL Lots
Distribution
Part of a larger recall action
This product is one of 26 recalled by Axium Healthcare Pharmacy dba Balanced Solutions Compounding under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 26 products in this recall →Related recalls
Same manufacturer · Axium Healthcare Pharmacy dba Balanced Solutions Compounding
See all →- SevereFDA Recalls Triamcinolone Diacetate Injectable Due to Sterility Concerns
FDA (Drugs) · 2013-05-01
- SevereFDA Recalls Methylcobalamin and Folic Acid Injectables Due to Sterility Concerns
FDA (Drugs) · 2013-05-01
- SevereMethylprednisolone Acetate Injectable Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2013-05-01
- SevereProgesterone Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2013-05-01
- SevereBiMix Standard Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2013-05-01
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereBiMix Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-08-21
- SevereBi-Mix Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23
- SevereBi-Mix #1 Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereBi-Mix Medium Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereTri-Mix Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereAssurance Infusion Recalls Bi-Mix Injections Due to Sterility Concerns
FDA (Drugs) · 2020-01-22